
Exhibit 99.1

COOPERATION AGREEMENT

This Cooperation Agreement (this "Agreement")  dated   December 12, 2014 , is by and among the persons and entities  listed  on Schedule A (collectively, the "ValueAct Group", and individually a "member" of the ValueAct Group), Allison Transmission Holdings, Inc. (the "Company") and Gregory P. Spivy, in his individual capacity and as a member of the ValueAct Group (the "ValueAct Designee"). WHEREAS, the ValueAct Group  currently  beneficially  owns  19,125,204 shares of the common stock, par value $0.01 per share, of the Company (the "Common Stock"), which  represents  approximately 10.77% of the issued and outstanding shares of Common Stock. WHEREAS, the Nominating and Governance Committee of the Board (the "Nominating Committee") and the Company's Board of Directors (the "Board") have  considered  the qualifications of the ValueAct Designee and  conducted  such review as they have  deemed  appropriate. WHEREAS, the Board has  determined  that it is in the best interests of the Company to  appoint  the ValueAct Designee on the terms set forth in this Agreement. NOW, THEREFORE, In consideration of and reliance upon the mutual covenants and agreements  contained  herein, and for other good and valuable consideration, the receipt and sufficiency of which is hereby  acknowledged  , the parties hereto  agree  as  follows  :

1. Board Nomination. (a) Subject to the satisfactory completion of the Company's customary background check, the Board shall  appoint  the ValueAct Designee to  serve  as a director  beginning  within ten (10) calendar  days   following  receipt of the ValueAct Group's  written  request to the Company to have the ValueAct Designee  appointed  to the Board;  provided  that, at such time, the Board  does  not  conclude  in good faith and  based  on the  written  opinion of outside legal counsel that such appointment would  constitute  a breach of the directors' fiduciary duties. If the ValueAct Designee is  appointed  to the Board pursuant to this Section 1(a), the Company shall  include  the ValueAct Designee as a Class I Director, which  term   expires  at the Company's  2016   annual  meeting of stockholders. (b) As a condition to the ValueAct Designee's appointment to the Board, the ValueAct Group,  including  the ValueAct Designee,  agrees  to  provide  to the Company information  required  to be or customarily  disclosed  for directors, candidates for directors, and their affiliates and representatives in a proxy statement or other filings under applicable law or stock exchange rules or  listing  standards, information in connection with  assessing  eligibility, independence and other criteria applicable to directors or  satisfying  compliance and legal obligations, and such other information as reasonably  requested  by the Company from time to time with respect to the ValueAct Group and the ValueAct Designee. (c) The ValueAct Designee  agrees  that, at all times while  serving  as a member of the Board, he will (i)  meet  all director independence and other standards of the Company, the New York Stock Exchange and the Securities and Exchange Commission ("SEC") and applicable provisions of the Securities Exchange Act of  1934 , as  amended  (the "Exchange Act"), and the rules and regulations  promulgated  thereunder,  including  Rule 10A- 3; and (ii) be qualified to  serve  as a director under the Delaware General Corporation Law (the "DGCL") (clauses (i) and (ii), the "Conditions"). The ValueAct Designee will promptly  advise  the Nominating Committee if he  ceases  to  satisfy  any of the Conditions. (d) At all times while  serving  as a member of the Board, the ValueAct Designee shall  comply  with all policies, procedures, processes, codes, rules, standards and guidelines applicable to Board members,  including  the Company's Code of Business Conduct, Insider Trading Policy, Executive Stock Ownership Policy as in effect on the date hereof, and Corporate Governance Guidelines, and (except as  permitted  by the Confidentiality Agreement (as  defined  in Section 7 below))  preserve  the confidentiality of Company business and information,  including  discussions or matters  considered  in meetings of the Board or Board committees to the extent not  disclosed  publicly by the Company. 1





(e) So long as the ValueAct Group collectively beneficially  owns  , in the aggregate, at least 7.5% of the outstanding Common Stock, if, during the Covered Period, a vacancy on the Board is  created  as a result of the ValueAct Designee's death, resignation, disqualification or removal, then the ValueAct Group and the Company ( acting  through the Board) shall  work  together in good faith to  fill  such vacancy or  replace  such nominee with an individual who (A)  meets  the Conditions, (B)  meets  the historical standards and criteria  applied  by the Company in  nominating  and  appointing  directors, and (C) is otherwise mutually acceptable (in each of their sole discretion) to the ValueAct Group and the Company, and thereafter such individual shall  serve  and/or be  nominated  as the "ValueAct Designee" under this Agreement. (f) The Company's obligations hereunder shall  terminate  immediately, and the ValueAct Designee shall promptly  offer  to  resign  from the Board, and any committee of the Board on which he then  sits  (and, if  requested  by the Company, promptly  deliver  his  written  resignation to the Board (which shall  provide  for his immediate resignation) it being  understood  that it shall be in the Board's sole discretion whether to  accept  or  reject  such resignation) if: (i) members of the ValueAct Group, collectively,  cease  to beneficially own at least 7.5% of the Company's outstanding Common Stock; (ii) the ValueAct Designee  ceases  to  satisfy  the conditions set forth in clauses (c)-(d) above; (iii) a member of the ValueAct Group,  including  the ValueAct Designee, otherwise  ceases  to  comply  or  breaches  any of the terms of this Agreement or the Confidentiality Agreement; or (iv) the employment of the ValueAct Designee with the ValueAct Group is  terminated  for any reason. The ValueAct Group  agrees  to  cause  the ValueAct Designee to  resign  from the Board if the ValueAct Designee  fails  to  resign  if and when  requested  pursuant to this Section 1(f). Notwithstanding the foregoing, in the event of the occurrence of an event set forth in subsection (ii) or (iv) above, the provisions of Section 1(e) must be  complied  with before the Company's obligations hereunder may  terminate  . (g) The percentage thresholds set forth in clauses (e) and (f) above shall not be  deemed  unsatisfied to the extent a failure to  maintain  the  specified  ownership thresholds is the result of share issuances or similar Company actions that  increase  the number of outstanding shares of Common Stock. 2. Standstill. (a) Each member of the ValueAct Group  agrees  that, during the Covered Period, (unless specifically  requested  in writing by the Company,  acting  through a resolution of a majority of the Company's directors not  including  the ValueAct Designee), it shall not, and shall  cause  each of its Affiliates or Associates (as such terms are  defined  in Rule 12b-2  promulgated  by the SEC under the Exchange Act) (collectively and individually, the "ValueAct Affiliates,"  provided  that no portfolio company of the ValueAct Group shall be  deemed  a "ValueAct Affiliate" so long as such portfolio company (A) has not  discussed  any of the actions set forth in this subsection (a) with the ValueAct Group or the ValueAct Designee, (B) has not  received  from the ValueAct Group or the ValueAct Designee information  concerning  the Company or its business, and (C) is not  acting  at the request of, in coordination with or on behalf of the ValueAct Group or the ValueAct Designee), not to, directly or indirectly, in any manner, alone or in concert with others:

(i)  make  ,  engage  in, or in any way  participate  in, directly or indirectly, any "solicitation" of proxies (as such terms are  used  in the proxy rules of the SEC but without regard to the exclusion set forth in Rule 14a-1(l)(2)(iv) of the Exchange Act) or  consents  to  vote  , or  seek  to  advise  ,  encourage  or  influence  any person with respect to the voting of any securities of the Company or any securities convertible or exchangeable into or exercisable for any such securities (collectively, "securities of the Company") for the election of individuals to the Board or to  approve  stockholder proposals, or  become  a "participant" in any contested "solicitation" for the election of directors with respect to the Company (as such terms are  defined  or  used  under the Exchange Act) (other than a "solicitation" or  acting  as a "participant" in support of all of the nominees of the Board at any stockholder meeting) or  make  or be the proponent of any stockholder proposal (pursuant to Rule 14a-8 under the Exchange Act or otherwise);

(ii) form,  join  ,  encourage  , influence,  advise  or in any way  participate  in any Group (as such  term  is  defined  in Section 13(d)(3) of the Exchange Act) with any persons who are not ValueAct Affiliates   2





with respect to any securities of the Company or otherwise in any manner  agree  ,  attempt  ,  seek  or  propose  to  deposit  any securities of the Company in any voting trust or similar arrangement, or  subject  any securities of the Company to any arrangement or agreement with respect to the voting thereof, except as expressly set forth in this Agreement;

(iii)  acquire  ,  offer  or  propose  to  acquire  , or  agree  to  acquire  , directly or indirectly, whether by purchase, tender or exchange offer, through the acquisition of control of another person, by  joining  a partnership, limited partnership, syndicate or other group ( including  any group of persons that would be  treated  as a single "person" under Section 13(d) of the Exchange Act), through swap or hedging transactions or otherwise, any securities of the Company or any rights  decoupled  from the  underlying  securities of the Company that would  result  in the ValueAct Group (together with the ValueAct Affiliates)  owning  , controlling or otherwise  having  any beneficial or other ownership interest in more than 12% in the aggregate of the shares of Common Stock outstanding at such time;  provided  , that, nothing herein will  require  Common Stock to be  sold  to the extent the ValueAct Group and the ValueAct Affiliates, collectively,  exceed  the ownership limit under this paragraph as the result of a share  repurchase  or similar Company actions that  reduces  the number of outstanding shares of Common Stock;

(iv) sell,  offer  or  agree  to  sell  directly or indirectly, through swap or hedging transactions or otherwise, the securities of the Company or any rights  decoupled  from the  underlying  securities of the Company  held  by the ValueAct Group or any ValueAct Affiliate to any person or entity not a (A) party to this Agreement, (B) member of the Board, (C) officer of the Company or (D) ValueAct Affiliate (any person or entity not set forth in clauses (A)-(D) shall be  referred  to as a "Third Party"), that would knowingly  result  in such Third Party, together with its affiliates and associates,  owning  , controlling or otherwise  having  any beneficial or other ownership interest in the aggregate of more than 4.9% of the shares of Common Stock outstanding at such time, except in a transaction  approved  by the Board;

(v) effect or  seek  to  effect  ,  offer  or  propose  to  effect  ,  cause  or  participate  in, or in any way assist or  facilitate  any other person to  effect  or  seek  ,  offer  or  propose  to  effect  or  participate  in, any tender or exchange offer, merger, consolidation, acquisition, scheme, arrangement, business combination, recapitalization, reorganization, sale or acquisition of material assets, liquidation, dissolution or other extraordinary transaction  involving  the Company or any of its subsidiaries or joint ventures or any of their respective securities (each, an "Extraordinary Transaction"), or  make  any public statement with respect to an Extraordinary Transaction;  provided  , however, that this clause shall not  preclude  the tender by the ValueAct Group or a ValueAct Affiliate of any securities of the Company into any tender or exchange offer or vote by the ValueAct Group or a ValueAct Affiliate of any securities of the Company with respect to any Extraordinary Transaction;

(vi)  engage  in any short sale or any purchase, sale or grant of any option, warrant, convertible security, stock appreciation right, or other similar right ( including  , without limitation, any put or  call  option or " swap  " transaction) with respect to any security (other than a broad-  based  market basket or index) that  includes  ,  relates  to or  derives  any significant part of its value from a decline in the market price or value of the securities of the Company;

(vii) (A) call or  seek  to  call  any meeting of stockholders,  including  by  written  consent, (B)  seek  representation, on or  nominate  any candidate to, the Board, except as set forth herein, (C)  seek  the removal of any member of the Board, (D) solicit consents from stockholders or otherwise act or  seek  to  act  by  written  consent, (E)  conduct  a referendum of stockholders, or (F)  make  a request for any stockholder list or other Company books and records, whether pursuant to Section 220 of the DGCL or otherwise;

(viii)  take  any action in support of or  make  any proposal or request that  constitutes  : (A)  advising  ,  controlling  ,  changing  or  influencing  the Board or management of the Company,  including  any plans or proposals to  change  the number or  term  of directors or to  fill  any vacancies on the Board; (B) any material change in the capitalization, stock  repurchase  programs and practices or dividend policy of the Company; (C) any other material change in the Company's management, business or corporate structure; (D)  seeking  to have the Company waive or  make  amendments or modifications to the Company's Certificate of Incorporation or Bylaws, or other actions that may  impede  or  facilitate  the acquisition of control of the Company by any person; (E)  causing  a class of securities of the Company to be  delisted  from, or to  cease  to be  authorized  to be  quoted  on, any securities exchange; or (F)  causing  a class of securities of the Company to  become  eligible for termination of registration pursuant to Section  12(g)(4  ) of the Exchange Act;   3





(ix) disparage or  cause  to be  disparaged  the Company or Affiliates thereof, any of its  current  or former officers, or directors;

(x)  make  any public disclosure, announcement or statement  regarding  any intent, purpose, plan or proposal with respect to the Board, the Company, its management, policies or affairs, any of its securities or assets or this Agreement that is inconsistent with the provisions of this Agreement;

(xi)  enter  into any substantive discussions, negotiations, agreements, or understandings with any Third Party with respect to any of the foregoing, or  advise  ,  assist  , knowingly  encourage  or  seek  to  persuade  any Third Party to  take  any action or  make  any statement with respect to any of the foregoing, or otherwise  take  or  cause  any action or  make  any statement inconsistent with any of the foregoing; or

(xii) request, directly or indirectly, any amendment or waiver of the foregoing. The  foregoing  provisions of this Section 2(a) shall not be  deemed  to  prohibit  the ValueAct Group or its directors, officers, partners, employees, members or agents ( acting  in such capacity) ("Representatives") from  communicating  privately with the Company's directors, officers or advisors so long as such communications are not  intended  to, and would not reasonably be  expected  to,  require  any public disclosure of such communications.
